These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
538 related items for PubMed ID: 14696486
1. Clinical features of patients with HCC who are negative for both HBV and HCV markers. Watabe H, Shiratori Y, Tateishi R, Fujishima T, Akamatsu M, Koike Y, Obi S, Hamamura K, Sato S, Teratani T, Shiina S, Omata M. Hepatogastroenterology; 2003; 50(54):2157-60. PubMed ID: 14696486 [Abstract] [Full Text] [Related]
2. Comparison of the clinical characteristics among hepatocellular carcinoma of hepatitis B, hepatitis C and non-B non-C patients. Dohmen K, Shigematsu H, Irie K, Ishibashi H. Hepatogastroenterology; 2003; 50(54):2022-7. PubMed ID: 14696457 [Abstract] [Full Text] [Related]
3. Clinicopathological features of hepatocellular carcinomas (HCCs) arising in patients without chronic viral infection or alcohol abuse: a retrospective study of patients undergoing hepatic resection. Yokoi Y, Suzuki S, Baba S, Inaba K, Konno H, Nakamura S. J Gastroenterol; 2005 Mar; 40(3):274-82. PubMed ID: 15830287 [Abstract] [Full Text] [Related]
4. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection. Uetake S, Yamauchi M, Itoh S, Kawashima O, Takeda K, Ohata M. Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):47S-51S. PubMed ID: 12960507 [Abstract] [Full Text] [Related]
5. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study. Matsuzaki Y, Sato M, Saito Y, Karube M, Doy M, Shoda J, Abei M, Tanaka N, Hadama T, Kinoshita M. J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185 [Abstract] [Full Text] [Related]
6. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma. Momosaki S, Nakashima Y, Kojiro M, Tabor E. J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475 [Abstract] [Full Text] [Related]
7. Comparison of liver resection for hepatocellular carcinoma in hepatitis B and hepatitis C-related cirrhotic patients. Wu CC, Tang JS, Lin MC, Yeh DC, Liu TJ, P'eng FK. Hepatogastroenterology; 1999 May; 46(26):651-5. PubMed ID: 10370591 [Abstract] [Full Text] [Related]
8. Possible contribution of prior hepatitis B virus infection to the development of hepatocellular carcinoma. Tanaka H, Iwasaki Y, Nouso K, Kobayashi Y, Nakamura S, Matsumoto E, Toshikuni N, Kaneyoshi T, Ohsawa T, Takaguchi K, Fujio K, Senoh T, Ohnishi T, Sakaguchi K, Shiratori Y. J Gastroenterol Hepatol; 2005 Jun; 20(6):850-6. PubMed ID: 15946131 [Abstract] [Full Text] [Related]
9. [Hepatocellular carcinoma in Germany. Epidemiology, etiology, clinical aspects and prognosis in 100 consecutive patients of a university clinic]. Petry W, Heintges T, Hensel F, Erhardt A, Wenning M, Niederau C, Häussinger D. Z Gastroenterol; 1997 Dec; 35(12):1059-67. PubMed ID: 9487638 [Abstract] [Full Text] [Related]
10. Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area. Huang YH, Wu JC, Chen CH, Chang TT, Lee PC, Chau GY, Lui WY, Chang FY, Lee SD. Liver Int; 2005 Apr; 25(2):236-41. PubMed ID: 15780044 [Abstract] [Full Text] [Related]
11. Clinical features of HBsAg-negative but anti-HBc-positive hepatocellular carcinoma in a hepatitis B virus endemic area. Shim J, Kim BH, Kim NH, Dong SH, Kim HJ, Chang YW, Lee JI, Chang R. J Gastroenterol Hepatol; 2005 May; 20(5):746-51. PubMed ID: 15853989 [Abstract] [Full Text] [Related]
12. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis]. Kim MJ, Kwon OS, Chung NS, Lee SY, Jung HS, Park DK, Ku YS, Kim YK, Kim YS, Kim JH. Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859 [Abstract] [Full Text] [Related]
13. Epidemiology and survival of hepatocellular carcinoma in Turkey: outcome of multicenter study. Alacacioglu A, Somali I, Simsek I, Astarcioglu I, Ozkan M, Camci C, Alkis N, Karaoglu A, Tarhan O, Unek T, Yilmaz U. Jpn J Clin Oncol; 2008 Oct; 38(10):683-8. PubMed ID: 18753360 [Abstract] [Full Text] [Related]
14. Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan? Shiratori Y, Shiina S, Zhang PY, Ohno E, Okudaira T, Payawal DA, Ono-Nita SK, Imamura M, Kato N, Omata M. Cancer; 1997 Dec 01; 80(11):2060-7. PubMed ID: 9392327 [Abstract] [Full Text] [Related]
15. Characteristics and prognosis of patients in Japan with viral marker-negative hepatocellular carcinoma. Toyoda H, Kumada T, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, Kanamori A, Yamaguchi A, Isogai M, Kaneoka Y, Washizu J. J Gastroenterol Hepatol; 2008 Mar 01; 23(3):459-66. PubMed ID: 17854425 [Abstract] [Full Text] [Related]
17. Impact of hepatitis B virus (HBV) X gene integration in liver tissue on hepatocellular carcinoma development in serologically HBV-negative chronic hepatitis C patients. Toyoda H, Kumada T, Kaneoka Y, Murakami Y. J Hepatol; 2008 Jan 01; 48(1):43-50. PubMed ID: 18023912 [Abstract] [Full Text] [Related]
19. Hepatitis B virus surface antigen-negative and hepatitis C virus antibody-negative hepatocellular carcinoma: clinical characteristics, outcome, and risk factors for early and late intrahepatic recurrence after resection. Li T, Qin LX, Gong X, Zhou J, Sun HC, Qiu SJ, Ye QH, Wang L, Fan J. Cancer; 2013 Jan 01; 119(1):126-35. PubMed ID: 22736338 [Abstract] [Full Text] [Related]